查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1757981

全球人工智慧（AI）辅助放射学市场

Artificial Intelligence (AI)-assisted Radiology
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年，全球人工智慧辅助放射学市场规模将达到 130 亿美元

全球人工智慧 (AI) 辅助放射学市场规模预计在 2024 年达到 23 亿美元，预计到 2030 年将达到 130 亿美元，2024 年至 2030 年的复合年增长率为 33.8%。 X 光技术是本报告分析的细分市场之一，预计其复合年增长率为 32.4%，到分析期结束时规模将达到 40 亿美元。磁振造影市场在分析期间的复合年增长率预计为 37.2%。

美国市场规模估计为 5.924 亿美元，中国市场预计复合年增长率为 32.2%

美国人工智慧 (AI) 辅助放射学市场规模预计在 2024 年达到 5.924 亿美元。预计到 2030 年，作为世界第二大经济体的中国市场规模将达到 19 亿美元，在 2024-2030 年的分析期内，复合年增长率为 32.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为 30.7% 和 29.4%。在欧洲，预计德国市场的复合年增长率约为 23.7%。

全球人工智慧（AI）辅助放射学市场－主要趋势与驱动因素摘要

人工智慧会改变放射科医师在诊断医学中的作用吗？

人工智慧 (AI) 正在推动放射学领域的重大转变，将其从单纯的诊断转变为集速度、准确性和预测洞察于一体的数据主导生态系统。与依赖人类专家进行影像解读的传统放射学不同，AI 辅助放射学利用机器学习演算法（尤其是深度学习网路）以极高的准确度分析医学影像。这些演算法是基于 X 光、 电脑断层扫描、MRI 和超音波的大量资料集进行训练，能够早期发现肿瘤、骨折、出血和感染疾病等异常情况。此功能有助于缩短週转时间并降低疏忽风险。 AI 并非取代放射科医生，而是作为第二双眼睛来增强他们的能力，以发现潜在问题并优先处理紧急病例。一些 AI 系统还可以将目前影像与先前的扫描结果进行比较，以检测可能预示病情进展或復发的细微变化。此外，AI 工具现在与自然语言处理相结合，有助于将影像解读转化为结构化的放射学报告，从而提高清晰度和一致性。随着这些系统日益复杂，放射科医师越来越专注于复杂的决策和病患沟通，承担起监督和咨询的角色，而人工智慧则负责大部分影像审查工作。这种转变正在重新定义放射科实践的范围，使其更加高效、主动，并与个人化医疗的目标一致。

临床效率和诊断准确性如何推动放射学领域人工智慧的应用？

由于 AI 能够大幅提高诊断准确性和临床工作流程效率，它正在加速应用于放射学。在负担过重的医疗系统中，放射科医生每天需要审查数千张影像，这增加了诊断错误和倦怠的风险。 AI 系统可以根据紧急程度自动对检查进行分类，标记异常情况，并识别可能被遗漏的偶然观察，从而帮助减轻这种负担。例如，AI 演算法可以在几秒钟内检测出肺结节、脑出血和骨折，有助于确保重要观察不会在阅读队列中延迟。除了标记异常之外，AI 还可以量化影像生物标记、测量病灶大小并高精度地追踪治疗反应，为临床决策提供有价值的背景资讯。工作流程最佳化也是一个关键优势。 AI 工具可以预先填入报告、捕捉相关的患者病历并简化影像搜寻，使放射科医师更专注于解释和临床会诊。在多学科环境中，人工智慧可以标准化影像分析并改善数据共用，从而促进放射科医生、肿瘤科医生、外科医生和基层医疗医生之间的有效沟通。此外，随着报销模式转向基于价值的医疗服务，医院和诊所面临越来越大的成果展示压力。人工智慧可以透过减少不必要的影像检查、缩短诊断时间并提高放射科医生之间的一致性来支持这一点。这些业务和诊断的优势不仅提高了医疗水平，也强化了人工智慧作为现代放射学策略工具的可行性。

人工智慧能否增加医疗服务不足地区获得放射科服务的机会？

人工智慧辅助放射学的巨大变革潜力在于，它能够填补缺乏熟练放射科医生和影像基础设施地区的诊断空白。世界上许多地区，尤其是农村和资源匮乏的地区，都严重缺乏放射肿瘤学专家，导致诊断延迟和患者预后不佳。人工智慧工具可以填补这一空白，它使非专科医生也能进行初步影像评估，并支援将本地诊所与集中式人工智慧平台连接起来的远端影像网路。这些系统可以预先筛检，并突出显示观察以供远端放射科医生审查，确保危重病例得到及时处理。可携式影像设备与人工智慧分析相结合，也使得在现场或护理点提供基本的诊断服务成为可能。在网路连接不稳定的环境中，边缘人工智慧设备正在成为一种可行的解决方案，它允许在无需持续存取云端的情况下进行离线影像处理。此外，人工智慧模型基于多样化的全球资料集进行训练，以提高其通用性并减少偏差，确保其在不同人群和显像模式下的性能稳健。作为医疗保健数位化和去中心化广泛努力的一部分，国际卫生组织和各国政府已开始投资人工智慧放射学倡议。透过自动化核心诊断任务并实现远端协作，人工智慧正在成为扩大放射学服务覆盖范围和公平性的催化剂，尤其是在人类专业知识匮乏的环境中。

推动人工智慧辅助放射学全球成长的关键因素有哪些？

人工智慧 (AI) 辅助放射学市场的成长受到技术、临床和机构驱动因素的共同推动，这些因素反映了现代医疗保健不断变化的需求。其中一个关键驱动因素是 AI 模型的快速发展，尤其是卷积类神经网路(CNN) 和 Transformer，它们显着提高了影像识别和分类任务的准确性。越来越多的大型註释医疗图像资料集对于训练和检验这些模型至关重要。同时，运算基础设施的改进，尤其是云端运算和边缘运算，促进了 AI 工具在临床环境中的部署，而无需进行大规模的 IT 改造。另一个主要驱动因素是癌症、心血管疾病和神经系统疾病等慢性疾病的负担日益加重，这些疾病需要持续的影像来诊断和监测治疗效果。 AI 增强了放射科在不增加人力的情况下应对日益增长的需求的能力。监管势头也促进了市场的成长。一些基于 AI 的放射学工具已经获得 FDA 和 CE 等机构的核准，这使得其临床应用的道路更加清晰。医院和影像中心积极采用人工智慧，不仅是为了其诊断效用，也是为了获得竞争优势、提高病患满意度，并顺应数位转型的步伐。来自创业投资、医疗科技公司和学术机构的投资正在进一步加速该领域的创新。这些力量共同催生了一个强劲且快速扩张的全球人工智慧辅助放射诊断市场，预计将重塑诊断成像的未来。

部分

技术（X 光技术、磁振造影技术、电脑断层扫描技术、正子断层扫描技术、其他技术）、应用（神经系统应用、乳房X光摄影应用、心血管应用、呼吸和骨科整形外科应用、其他应用）、最终用途（医院最终用途、诊断影像中心最终用途、其他最终用途）

受访公司范例（48家值得关注的公司）

  • Aidoc
  • Arterys
  • Butterfly Network
  • Caption Health
  • ContextVision
  • CureMetrix
  • EnvoyAI
  • iCAD
  • Infervision
  • MaxQ AI
  • Maximal Tech
  • MedyMatch Technology
  • Nanox
  • Qure.ai
  • Rad AI
  • Radboudumc（Radboud University Medical Center）
  • Riverain Technologies
  • Siemens Healthineers
  • Zebra Medical Vision
  • Zegami

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP36209

Global Artificial Intelligence (AI)-assisted Radiology Market to Reach US$13.0 Billion by 2030

The global market for Artificial Intelligence (AI)-assisted Radiology estimated at US$2.3 Billion in the year 2024, is expected to reach US$13.0 Billion by 2030, growing at a CAGR of 33.8% over the analysis period 2024-2030. X-Ray Technique, one of the segments analyzed in the report, is expected to record a 32.4% CAGR and reach US$4.0 Billion by the end of the analysis period. Growth in the Magnetic Resonance Imaging Technique segment is estimated at 37.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$592.4 Million While China is Forecast to Grow at 32.2% CAGR

The Artificial Intelligence (AI)-assisted Radiology market in the U.S. is estimated at US$592.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2030 trailing a CAGR of 32.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 30.7% and 29.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 23.7% CAGR.

Global Artificial Intelligence (AI)-Assisted Radiology Market - Key Trends & Drivers Summarized

Is AI Transforming the Role of Radiologists in Diagnostic Medicine?

Artificial Intelligence (AI) is bringing a profound shift to the field of radiology, transitioning it from a purely diagnostic discipline to a data-driven ecosystem that integrates speed, precision, and predictive insights. Unlike traditional radiology, which relies on the interpretation of images by human specialists, AI-assisted radiology leverages machine learning algorithms-especially deep learning networks-to analyze medical images with exceptional accuracy. These algorithms are trained on vast datasets of X-rays, CT scans, MRIs, and ultrasounds, enabling them to detect anomalies such as tumors, fractures, hemorrhages, and infections at an early stage. This capability allows for faster turnaround times and reduces the risk of oversight, which is particularly crucial in high-volume clinical settings. Rather than replacing radiologists, AI augments their capabilities by acting as a second set of eyes, flagging potential issues and prioritizing urgent cases. Some AI systems can even compare current images with prior scans to detect subtle changes that may signal disease progression or recurrence. Additionally, AI tools are now being integrated with natural language processing to help convert image interpretations into structured radiology reports, enhancing clarity and consistency. As these systems become more sophisticated, radiologists are increasingly taking on a supervisory and consultative role, focusing on complex decision-making and patient communication while AI handles the bulk of image review. This shift is redefining the scope of radiological practice, making it more efficient, proactive, and aligned with personalized medicine goals.

How Are Clinical Efficiency and Diagnostic Accuracy Driving AI Adoption in Radiology?

The adoption of AI in radiology is accelerating due to its ability to dramatically enhance diagnostic accuracy and clinical workflow efficiency. In overburdened healthcare systems, radiologists often face the challenge of reviewing thousands of images daily, increasing the risk of diagnostic errors and burnout. AI systems help alleviate this burden by automatically triaging studies based on urgency, flagging abnormalities, and even identifying incidental findings that may otherwise be missed. For instance, AI algorithms can detect lung nodules, brain bleeds, or bone fractures in seconds, helping ensure that critical findings are not delayed in the reading queue. Beyond flagging abnormalities, AI can quantify imaging biomarkers, measure lesion dimensions, and track treatment responses with high precision, adding valuable context to clinical decisions. Workflow optimization is another key benefit-AI tools can pre-populate reports, retrieve relevant patient history, and streamline image retrieval, allowing radiologists to focus more on interpretation and clinical consultation. In multidisciplinary care settings, AI facilitates better communication between radiologists, oncologists, surgeons, and primary care physicians by standardizing image analysis and improving data sharing. Furthermore, as reimbursement models shift toward value-based care, hospitals and clinics are under pressure to demonstrate outcomes. AI supports this by reducing unnecessary imaging, shortening diagnosis timelines, and improving consistency across radiologists. These operational and diagnostic benefits are not only elevating the standard of care but also strengthening the case for AI as a strategic tool in modern radiology departments.

Can AI Widen Access to Radiology Services in Underserved Regions?

A major transformative potential of AI-assisted radiology lies in its ability to bridge the diagnostic gap in regions with limited access to skilled radiologists and imaging infrastructure. In many parts of the world, particularly rural and low-resource settings, there is a severe shortage of radiology professionals, leading to delayed diagnoses and compromised patient outcomes. AI tools can help fill this void by enabling non-specialists to perform preliminary image evaluations and by supporting teleradiology networks that connect local clinics with centralized AI platforms. These systems can pre-screen scans and highlight findings for review by remote radiologists, ensuring that critical cases receive timely attention. Portable imaging devices paired with AI analysis are also making it feasible to deliver basic diagnostic services in the field or at the point of care. In settings where internet connectivity is unreliable, edge AI devices are emerging as a viable solution, allowing offline image processing without the need for constant cloud access. Moreover, AI models are being trained on diverse global datasets to improve their generalizability and reduce bias, ensuring that their performance remains robust across different populations and imaging modalities. International health organizations and governments are beginning to invest in AI radiology initiatives as part of broader efforts to digitize and decentralize healthcare. By automating core diagnostic tasks and enabling remote collaboration, AI is becoming a catalyst for expanding the reach and equity of radiology services, particularly in environments where human expertise is scarce.

What Are the Key Forces Fueling Global Growth in AI-Assisted Radiology?

The growth in the artificial intelligence (AI)-assisted radiology market is driven by a confluence of technological, clinical, and institutional dynamics that reflect the evolving demands of modern healthcare. One of the primary drivers is the rapid advancement of AI models, particularly convolutional neural networks (CNNs) and transformers, which have dramatically improved the accuracy of image recognition and classification tasks. The growing availability of large, annotated medical imaging datasets has been essential in training and validating these models. At the same time, improvements in computational infrastructure-especially in cloud and edge computing-have made it easier to deploy AI tools in clinical settings without the need for extensive IT overhauls. Another major factor is the increasing burden of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions, which require continuous imaging for diagnosis and treatment monitoring. AI enhances the capacity of radiology departments to manage this rising demand without proportionally increasing manpower. Regulatory momentum is also contributing to market growth; with several AI-based radiology tools already approved by agencies such as the FDA and CE, the pathway to clinical adoption is becoming clearer. Hospitals and imaging centers are motivated to adopt AI not only for its diagnostic utility but also to gain a competitive edge, improve patient satisfaction, and align with digital transformation initiatives. Investment from venture capital, health tech companies, and academic institutions is further accelerating innovation in the space. Together, these forces are creating a robust and rapidly expanding global market for AI-assisted radiology that promises to reshape the future of diagnostic imaging.

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence (AI)-assisted Radiology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technique (X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique, Other Techniques); Application (Neurology Application, Mammography Application, Cardiovascular Application, Respiratory & Pulmonary Orthopedics Application, Other Applications); End-Use (Hospitals End-Use, Diagnostic Imaging Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 48 Featured) -

  • Aidoc
  • Arterys
  • Butterfly Network
  • Caption Health
  • ContextVision
  • CureMetrix
  • EnvoyAI
  • iCAD
  • Infervision
  • MaxQ AI
  • Maximal Tech
  • MedyMatch Technology
  • Nanox
  • Qure.ai
  • Rad AI
  • Radboudumc (Radboud University Medical Center)
  • Riverain Technologies
  • Siemens Healthineers
  • Zebra Medical Vision
  • Zegami

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Artificial Intelligence (AI)-assisted Radiology - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Early and Accurate Diagnostic Imaging Spurs Market Growth
    • Growing Radiologist Shortages Accelerate Demand for AI-assisted Workflows
    • Need for Operational Efficiency Strengthens the Business Case for Radiology AI
    • Integration of AI into Clinical Decision-making Pathways Drives Adoption
    • Digital Transformation Initiatives Across Hospitals Propel AI Deployment
    • Cloud-based Imaging Platforms Expand the Addressable Market for AI Solutions
    • AI Innovation in Multi-modal Imaging and Federated Learning Unlocks New Opportunities
    • Value-based Care Models Throw the Spotlight on Outcome-driven Imaging Solutions
    • Wider Acceptance of AI-as-a-Service Models Generates Demand Among Smaller Clinics
    • Shift Toward Predictive and Prognostic Imaging Use-cases Raises Innovation Standards
    • Growing Concerns Around Data Privacy and Algorithmic Bias Create Adoption Barriers
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence (AI)-assisted Radiology Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for X-Ray Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for X-Ray Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Magnetic Resonance Imaging Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Magnetic Resonance Imaging Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Computed Tomography Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Computed Tomography Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Positron Emission Tomography Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Positron Emission Tomography Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Neurology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Neurology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Mammography Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Mammography Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cardiovascular Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Cardiovascular Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Respiratory & Pulmonary Orthopedics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Respiratory & Pulmonary Orthopedics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostic Imaging Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Diagnostic Imaging Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence (AI)-assisted Radiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 30: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Technique - X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Technique - Percentage Breakdown of Value Sales for X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Application - Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Application - Percentage Breakdown of Value Sales for Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • CANADA
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Technique - X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Technique - Percentage Breakdown of Value Sales for X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques for the Years 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Application - Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Application - Percentage Breakdown of Value Sales for Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence (AI)-assisted Radiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Technique - X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Technique - Percentage Breakdown of Value Sales for X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques for the Years 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Application - Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Application - Percentage Breakdown of Value Sales for Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application for the Years 2025 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence (AI)-assisted Radiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 48: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Technique - X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Technique - Percentage Breakdown of Value Sales for X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques for the Years 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Application - Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Application - Percentage Breakdown of Value Sales for Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application for the Years 2025 & 2030
    • TABLE 52: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: China 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence (AI)-assisted Radiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Technique - X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Technique - Percentage Breakdown of Value Sales for X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques for the Years 2025 & 2030
    • TABLE 58: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Application - Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Europe 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Application - Percentage Breakdown of Value Sales for Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application for the Years 2025 & 2030
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Europe 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence (AI)-assisted Radiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Technique - X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Technique - Percentage Breakdown of Value Sales for X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques for the Years 2025 & 2030
    • TABLE 64: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Application - Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: France 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Application - Percentage Breakdown of Value Sales for Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application for the Years 2025 & 2030
    • TABLE 66: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: France 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence (AI)-assisted Radiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Technique - X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Technique - Percentage Breakdown of Value Sales for X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques for the Years 2025 & 2030
    • TABLE 70: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Application - Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Germany 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Application - Percentage Breakdown of Value Sales for Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application for the Years 2025 & 2030
    • TABLE 72: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Germany 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Technique - X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Technique - Percentage Breakdown of Value Sales for X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques for the Years 2025 & 2030
    • TABLE 76: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Application - Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Italy 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Application - Percentage Breakdown of Value Sales for Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application for the Years 2025 & 2030
    • TABLE 78: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Italy 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence (AI)-assisted Radiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Technique - X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Technique - Percentage Breakdown of Value Sales for X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques for the Years 2025 & 2030
    • TABLE 82: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Application - Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: UK 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Application - Percentage Breakdown of Value Sales for Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application for the Years 2025 & 2030
    • TABLE 84: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: UK 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Technique - X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Technique - Percentage Breakdown of Value Sales for X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques for the Years 2025 & 2030
    • TABLE 88: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Application - Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of Europe 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Application - Percentage Breakdown of Value Sales for Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application for the Years 2025 & 2030
    • TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of Europe 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence (AI)-assisted Radiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Technique - X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Technique - Percentage Breakdown of Value Sales for X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques for the Years 2025 & 2030
    • TABLE 94: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Application - Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Asia-Pacific 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Application - Percentage Breakdown of Value Sales for Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application for the Years 2025 & 2030
    • TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Asia-Pacific 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Technique - X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Technique - Percentage Breakdown of Value Sales for X-Ray Technique, Magnetic Resonance Imaging Technique, Computed Tomography Technique, Positron Emission Tomography Technique and Other Techniques for the Years 2025 & 2030
    • TABLE 100: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by Application - Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Rest of World 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by Application - Percentage Breakdown of Value Sales for Other Applications, Neurology Application, Mammography Application, Cardiovascular Application and Respiratory & Pulmonary Orthopedics Application for the Years 2025 & 2030
    • TABLE 102: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI)-assisted Radiology by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of World 6-Year Perspective for Artificial Intelligence (AI)-assisted Radiology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030

IV. COMPETITION